Remimazolam hydrobromide (Chengdu Beite )
氢溴酸瑞马唑仑（成都倍特药业）
Report date: 2022/11/11 09:55:15
Base Information
Drug NameRemimazolam hydrobromide (Chengdu Beite )
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesChengdu Brilliant Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesChengdu Brilliant Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A